Suven Life Science said on Tuesday that it has been granted one patent each by the US, Israel and Macau for a drug that is used in the treatment of neurodegenerative diseases.

The company in a BSE filing said that it has been granted “one product patent from Israel, one product patent from Macau and one product patent from USA corresponding to their New Chemical Entities (NCEs) for the treatment of disorders associated with neurodegenerative diseases”.

Alzheimer’s, Schizophrenia and Parkinson’s are included in
Neurodegenerative diseases.

Get which are the best stocks to buy in India